But either way, you can call the clinic where the Oncolix trials are taking place and they will tell you that in the initial phase I, efficacy was observed as in anti-tumor activity. So it's a statement that holds truth and theres no way around it. Observing efficacy in phase I is just a bonus on top of what is the main purpose of phase I, which is to find out the safety and tolerability of the drug.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.